AURKA and glioblastoma: In regards to GBM, combination of MP7 (Figure 4D) (characterized in [108]) and alisertib which are PDK1 and Aurora Kinase A (AurA) inhibitors respectively, exhibited higher potential of reducing both the proliferation of GBM cells and their respective tumorspheres, than sole administration of each agent.